Internal Server Error

ProtaGene - About the company

ProtaGene is a series B company based in Heilbronn (Germany), founded in 2004 by Martin Blüggel. It operates as a Provider of drug development services for cell & gene therapeutic services. ProtaGene has raised $4.61M in funding. The company has 438 active competitors, including 106 funded and 51 that have exited. Its top competitors include companies like Oxford Instruments, Liquidia and FEI Company.

Company Details

Social
X
Key Metrics
Founded Year
2004
Location
Heilbronn, Germany
Stage
Series B
Total Funding
$4.61M in 2 rounds
Latest Funding Round
Ranked
Employee Count
132 as on Sep 30, 2026
Similar Companies
Sign up to download ProtaGene's company profile

ProtaGene's funding and investors

ProtaGene has raised a total funding of $4.61M over 2 rounds. Its first funding round was on Aug 15, 2012. ProtaGene has 2 institutional investors.

Here is the list of recent funding rounds of ProtaGene:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 02, 2013
4855825
Series B
7339406
5105566
4899375
2560380
Aug 15, 2012
1276733
Seed
6454213
9937601
9401775
5775148
lockAccess funding benchmarks and valuations. Sign up today!

ProtaGene's founders and board of directors

Founder? Claim Profile
The founders of ProtaGene is Martin Blüggel.
Here are the details of ProtaGene's key team members:

ProtaGene's employee count trend

ProtaGene has 132 employees as of Sep 26. Here is ProtaGene's employee count trend over the years:
Employee count trend for ProtaGene
lockUncover ProtaGene's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

ProtaGene's Competitors and alternates

Top competitors of ProtaGene include Oxford Instruments, Liquidia and FEI Company. Here is the list of Top 10 competitors of ProtaGene, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Oxford Instruments
Oxford Instruments
1959, High Wycombe (United Kingdom), Public
Manufacturer of scientific technology for atomic and molecular level research
-
69/100
2nd
Logo for Liquidia
Liquidia
2004, Morrisville (United States), Public
Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions
$90.3M
68/100
3rd
Logo for FEI Company
FEI Company
1971, Hillsboro (United States), Acquired
Electron microscopy solutions for advancing scientific discovery and industrial innovation
$300K
65/100
4th
Logo for Genedit
Genedit
2016, Berkeley (United States), Series B
Developer of drug delivery system for genetic medicines
$93.5M
65/100
5th
Logo for Blue Rock Therapeutics
Blue Rock Therapeutics
2016, Boston (United States), Acquired
Stem cell therapies for cardiovascular and neurological diseases
$225M
62/100
6th
Logo for Aera
Aera
2021, Boston (United States), Series B
Developer of genetic medicines across a wide range of therapeutic areas
$193M
62/100
7th
Logo for NanoSyrinx
NanoSyrinx
2018, Coventry (United Kingdom), Series A
Developer of targeted intracellular delivery platform for biological molecules
$21.6M
61/100
8th
Logo for CellCarta
CellCarta
2002, Montreal (Canada), Acquired
CRO focused on providing histopathology and genomics services
$7.5M
59/100
9th
Logo for Helex
Helex
2021, New York City (United States), Seed
Provider of next-generation gene-editing therapies
$6M
59/100
10th
Logo for InnoMedica
InnoMedica
2000, Bern (Switzerland), Acquired
Developer of therapeutics to treat cancer
$10.3M
-
57/100
102nd
Logo for ProtaGene
ProtaGene
2004, Heilbronn (Germany), Series B
Provider of drug development services for cell & gene therapeutic services
$4.61M
33/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on ProtaGene's competitors? Click here to see the top ones

ProtaGene's Investments and acquisitions

ProtaGene has made no investments or acquisitions yet.

Reports related to ProtaGene

Here is the latest report on ProtaGene's sector:

News related to ProtaGene

•
The Business Journals•ProtaGene
•
The Business Journals•ProtaGene
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about ProtaGene

Explore our recently published companies
  • Way - Helsinki based, 2024 founded, Seed company
  • Delite - Hyderabad based, 2010 founded, Unfunded company
  • Yuki - Tel Aviv based, 2023 founded, Seed company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford